This grant, offered by the National Institutes of Health (NIH), is for the purpose of accelerating the development of safe and effective long-acting drug delivery systems. The aim is to achieve improved and simplified HIV-1 treatment specifically for children. It invites applicants who are engaged in the early stages of developing existing long-acting platforms. The funding supports crucial preclinical activities designed to optimize products and expedite their translation into beneficial therapies for HIV-infected children. A mandatory requirement for all applicants is the establishment of collaborative research partnerships with industry, ensuring a direct pathway from research innovation to clinical application and improved patient care.
Opportunity ID: 350712
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-AI-23-061 |
| Funding Opportunity Title: | Long-Acting Drug Delivery Systems for ART Optimization in Children Living with HIV-1 II (LADDS II) (R61/R33 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health Income Security and Social Services |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.242 — Mental Health Research Grants |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Oct 25, 2023 |
| Last Updated Date: | Oct 25, 2023 |
| Original Closing Date for Applications: | Mar 13, 2024 |
| Current Closing Date for Applications: | Mar 13, 2024 |
| Archive Date: | Apr 18, 2024 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $850,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses State governments For profit organizations other than small businesses County governments Public housing authorities/Indian housing authorities Others (see text field entitled “Additional Information on Eligibility” for clarification) Private institutions of higher education Native American tribal governments (Federally recognized) Independent school districts City or township governments Special district governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Notice of Funding Opportunity (NOFO) is to accelerate the development of safe and effective long-acting drug delivery systems for improved, simplified treatment of HIV-1 in children. This NOFO invites applicants engaged in the development of existing long-acting platforms at early stages of development stages to perform specific preclinical activities that enable product optimization and accelerated translation to HIV-infected children. Collaborative research partnerships with industry are required. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-23-061.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 350712 Full Announcement-RFA-AI-23-061 -> RFA-AI-23-061-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00283595 | Feb 13, 2024 | Mar 13, 2024 | View |
Package 1
Mandatory forms
350712 RR_SF424_5_0-5.0.pdf
350712 PHS398_CoverPageSupplement_5_0-5.0.pdf
350712 RR_OtherProjectInfo_1_4-1.4.pdf
350712 PerformanceSite_4_0-4.0.pdf
350712 RR_KeyPersonExpanded_4_0-4.0.pdf
350712 RR_Budget10_3_0-3.0.pdf
350712 PHS398_ResearchPlan_5_0-5.0.pdf
350712 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
350712 RR_SubawardBudget10_30_3_0-3.0.pdf
350712 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
